BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37550596)

  • 1. Asparagine restriction enhances CD8
    Gnanaprakasam JNR; Kushwaha B; Liu L; Chen X; Kang S; Wang T; Cassel TA; Adams CM; Higashi RM; Scott DA; Xin G; Li Z; Yang J; Lane AN; Fan TW; Zhang J; Wang R
    Nat Metab; 2023 Aug; 5(8):1423-1439. PubMed ID: 37550596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asparagine enhances LCK signalling to potentiate CD8
    Wu J; Li G; Li L; Li D; Dong Z; Jiang P
    Nat Cell Biol; 2021 Jan; 23(1):75-86. PubMed ID: 33420490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of transcription factor nuclear factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) leads to dysregulation of immune functions, redox homeostasis, and intracellular signaling in dendritic cells.
    Yeang HXA; Hamdam JM; Al-Huseini LMA; Sethu S; Djouhri L; Walsh J; Kitteringham N; Park BK; Goldring CE; Sathish JG
    J Biol Chem; 2012 Mar; 287(13):10556-10564. PubMed ID: 22311972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes.
    Nishida M; Yamashita N; Ogawa T; Koseki K; Warabi E; Ohue T; Komatsu M; Matsushita H; Kakimi K; Kawakami E; Shiroguchi K; Udono H
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability.
    Sha LK; Sha W; Kuchler L; Daiber A; Giegerich AK; Weigert A; Knape T; Snodgrass R; Schröder K; Brandes RP; Brüne B; von Knethen A
    Free Radic Biol Med; 2015 Jun; 83():77-88. PubMed ID: 25687825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress.
    Renken S; Nakajima T; Magalhaes I; Mattsson J; Lundqvist A; Arnér ESJ; Kiessling R; Wickström SL
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8+ T cells.
    Wu Z; Huang H; Han Q; Hu Z; Teng XL; Ding R; Ye Y; Yu X; Zhao R; Wang Z; Zou Q
    J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35143421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming.
    Mitsuishi Y; Taguchi K; Kawatani Y; Shibata T; Nukiwa T; Aburatani H; Yamamoto M; Motohashi H
    Cancer Cell; 2012 Jul; 22(1):66-79. PubMed ID: 22789539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRF2, cancer and calorie restriction.
    Martín-Montalvo A; Villalba JM; Navas P; de Cabo R
    Oncogene; 2011 Feb; 30(5):505-20. PubMed ID: 21057541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor E2-related factor 2 knockdown enhances glucose uptake and alters glucose metabolism in AML12 hepatocytes.
    Yuan X; Huang H; Huang Y; Wang J; Yan J; Ding L; Zhang C; Zhang L
    Exp Biol Med (Maywood); 2017 May; 242(9):930-938. PubMed ID: 28440735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of immune-activating metabolite for enhancing T cell therapy of cancer.
    Cong B; Cui Z; Cao X
    Cancer Commun (Lond); 2021 Jul; 41(7):535-537. PubMed ID: 34004061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 agonism functionally activates memory T cells and enhances antitumor immunity.
    Madi A; Weisshaar N; Buettner M; Poschet G; Ma S; Wu J; Mieg A; Hering M; Ming Y; Mohr K; Ten Bosch N; Cui G
    Int J Cancer; 2022 Sep; 151(5):797-808. PubMed ID: 35499751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GOT1 regulates CD8
    Xu W; Patel CH; Zhao L; Sun IH; Oh MH; Sun IM; Helms RS; Wen J; Powell JD
    Cell Rep; 2023 Jan; 42(1):111987. PubMed ID: 36640309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8
    Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S
    J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors.
    Hayashi M; Kuga A; Suzuki M; Panda H; Kitamura H; Motohashi H; Yamamoto M
    Cancer Res; 2020 Aug; 80(16):3331-3344. PubMed ID: 32636316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer.
    Nukui A; Narimatsu T; Kambara T; Abe H; Sakamoto S; Yoshida KI; Kamai T
    BMC Cancer; 2018 May; 18(1):493. PubMed ID: 29716554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pterostilbene in attenuating immune mediated devastation of pancreatic beta cells via Nrf2 signaling cascade.
    Sireesh D; Ganesh MR; Dhamodharan U; Sakthivadivel M; Sivasubramanian S; Gunasekaran P; Ramkumar KM
    J Nutr Biochem; 2017 Jun; 44():11-21. PubMed ID: 28343084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression.
    Finisguerra V; Dvorakova T; Formenti M; Van Meerbeeck P; Mignion L; Gallez B; Van den Eynde BJ
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37147018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble γc receptor attenuates anti-tumor responses of CD8
    Kim G; Hwang H; Jo Y; Lee B; Lee YH; Kim CH; Hong C
    Int J Cancer; 2018 Sep; 143(5):1212-1223. PubMed ID: 29577276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.